| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/10/2005 | US20050032869 Antitumor, anticarcinogenic, antiproliferative, and antimetastasis agents; tyrosine kinase inhibitors; autoimmune, nervous system, neurodegenerative, and skin disorders; neurofibromatosis, atherosclerosis, graft versus host disease, glomerulonephritiis, hyperplasia; angiogenesis inhibitors |
| 02/10/2005 | US20050032868 Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 02/10/2005 | US20050032862 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 02/10/2005 | US20050032810 Novel anthelmintic and insecticidal compositions |
| 02/10/2005 | US20050032809 5-HT receptor ligands and uses thereof |
| 02/10/2005 | US20050032805 Antimicrobial biaryl compounds |
| 02/10/2005 | US20050032792 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 02/10/2005 | US20050032791 Derivatives of sulphonamides, their preparation and use as medicaments |
| 02/10/2005 | US20050032790 For example, 1-(2-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4,4'-bispiperidine; for treatment of thrombosis, emphysema, cirrhosis; antiarthritic agents, anticancer agents, antihistamines |
| 02/10/2005 | US20050032772 Compounds useful as reversible inhibitors of cysteine proteases |
| 02/10/2005 | US20050032752 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/10/2005 | US20050031993 Cyanine compound, optical recording material, and optical recording medium |
| 02/10/2005 | US20050031899 Carbazole derivative, organic semiconductor element, light emitting element, and electronic device |
| 02/10/2005 | DE10331675A1 Hetarylsubstituierte Pyrazolidindion-Derivate Hetarylsubstituierte pyrazolidindione derivatives |
| 02/10/2005 | CA2534649A1 Bicyclic imidazol derivatives against flaviviridae |
| 02/10/2005 | CA2534451A1 Angiotensin ii receptor blocker derivatives |
| 02/10/2005 | CA2534038A1 Inhibitors of akt activity |
| 02/10/2005 | CA2533901A1 Piperazine derivatives and their use as therapeutic agents |
| 02/10/2005 | CA2533474A1 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| 02/10/2005 | CA2533102A1 Method for characterising polypeptides by maldi-tof mas spectrometry |
| 02/10/2005 | CA2532965A1 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 02/09/2005 | EP1505125A1 Cyanine compound, optical recording material, and optical recording medium |
| 02/09/2005 | EP1505064A1 2-Aminopyrimidine derivatives |
| 02/09/2005 | EP1505063A1 Benzimidazole derivatives |
| 02/09/2005 | EP1505061A1 Compound exhibiting pgd 2 receptor antagonism |
| 02/09/2005 | EP1504008A1 7-aminoimidazotriazones |
| 02/09/2005 | EP1503996A1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 02/09/2005 | EP1503994A1 Substituted (thioxo)carbonylamino phenyl uraciles |
| 02/09/2005 | EP1503993A2 Compounds, methods and compositions |
| 02/09/2005 | EP1503991A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof |
| 02/09/2005 | EP1503988A2 Fredericamycin derivatives |
| 02/09/2005 | EP1503761A1 Substituted piperazines as melanocortin receptor ligands |
| 02/09/2005 | EP1503754A1 Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
| 02/09/2005 | EP1430047B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1430034B1 Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 02/09/2005 | EP1414816B1 Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
| 02/09/2005 | EP1349839B1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/09/2005 | EP1105376B1 Oxindole derivatives as growth hormone releasers |
| 02/09/2005 | CN1578773A Methods and compositions of novel triazine compounds |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1576275A Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188408C Process for extracting heme from animal blood |
| 02/09/2005 | CN1188407C Imidazole derivatives with farnesyl transferase to inhibite activity and preparing method thereof |
| 02/09/2005 | CN1188399C New pyrazolone compound and eye plastic lens made therefrom |
| 02/08/2005 | US6852752 Urea compounds, compositions and methods of use and preparation |
| 02/08/2005 | US6852749 Pyrazolidinol compounds |
| 02/08/2005 | US6852748 Derivatives of 6,7-dihydro-5H-imidazo(1,2- alpha )imidazole-3- sulfonyl)-pyrrolidine-2-carboxylic acid amide which exhibit good inhibitory effect upon the interaction of CAMs and Leukointegrins and are thus useful in the treatment |
| 02/08/2005 | US6852745 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 02/08/2005 | US6852743 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
| 02/08/2005 | US6852726 Such as 1-(4,5-dihydro-1H-imidazol-2-ylmethyl)-3-methanesulfonyl-2-methyl-1H-indole for preventing/treating disorders modulated by alpha-1A/L adrenoceptors such as urinary incontinence and sexual disorders |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852717 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor; for use in therapy of diseases and pathological conditions involving inflammation such as chronic inflammatory disease |
| 02/08/2005 | US6852712 Controlling cell differentiation; antiinflammatory agents |
| 02/08/2005 | CA2112081C Imidazole compounds, their preparation and use |
| 02/08/2005 | CA2097208C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 02/03/2005 | WO2005009993A1 Novel compounds |
| 02/03/2005 | WO2005009992A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | WO2005009978A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | WO2005009975A2 Benzimidazole derivatives as mek inhibitors |
| 02/03/2005 | WO2005009973A1 5-membered heterocycle-based p38 kinase inhibitors |
| 02/03/2005 | WO2005009968A1 Quinoline derivates and their use in therapy |
| 02/03/2005 | WO2005009957A1 Tyrosine kinase inhibitors |
| 02/03/2005 | WO2005009435A1 Aminopyrazole compounds and use as chk1 inhibitors |
| 02/03/2005 | WO2004106307A3 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 02/03/2005 | WO2004075840A3 Selective non-steroidal glucocorticoid receptor modulators |
| 02/03/2005 | US20050027121 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases |
| 02/03/2005 | US20050026989 treatment or prophylaxis of cardiovascular disease, metabolic disease, cancerous disease, or fibrotic disease; arrhythmias, life-threatening cardiac ventricular fibrillation, myocardial infarction, angina pectoris; ischemic states of the heart, diabetes |
| 02/03/2005 | US20050026987 CBI analogues of the duocarmycins and CC-1065 |
| 02/03/2005 | US20050026985 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility |
| 02/03/2005 | US20050026981 Stable oral solid drug composition |
| 02/03/2005 | US20050026975 Such as ethyl 4-chloroacetamido-N-(3,4-dichlorobenzyl)indole-2-carboxylate use in the treatment of disease mediated by monocyte chemoattractant protein-1 |
| 02/03/2005 | US20050026970 Antiproliferative agents, enzyme inhibitor for treating cancer, restenosis, psoriasis, autoimmune disease, atherosclerosis, osteoarthritis, rheumatoid arthritis, heart failure, chronic pain, and neuropathic pain; chemical synthesis |
| 02/03/2005 | US20050026968 Heterocyclic amides with anti-tuberculosis activity |
| 02/03/2005 | US20050026963 Pyrazole substituted directly, or by a bridge, with a heteroaryl group containing N adjacent to the point of connection of the heteroaryl useful in the treatment of psychiatric and mood disorders such as, schizophrenia, anxiety, depression, bipolar disorder, circadian rhythm and sleep disorders |
| 02/03/2005 | US20050026936 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026927 Pyrazole derivatives as psychopharmaceuticals |
| 02/03/2005 | US20050026923 For therapy of viral diseases |
| 02/03/2005 | US20050026914 Pyrimidine or pyridine carbamate compounds as for example 1,1-dimethylethyl 4-(4-((4-((((2,6-dimethylphenyl)oxy)carbonyl)(4-(methyloxy)phenyl)amino)-2-pyrimidinyl)amino)phenyl)-1-piperazinecarboxylate; for the treatment of protein tyrosine kinase-associated disorders |
| 02/03/2005 | US20050026911 Benzotriazapinone salts and methods for using same |
| 02/03/2005 | US20050026905 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 02/03/2005 | US20050026903 Pyrazole compound; gastrointestinal disorders; central nervous system disorders |
| 02/03/2005 | US20050026174 Alternative heterocycles for DNA recognition |
| 02/03/2005 | US20050025774 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS |
| 02/03/2005 | CA2770493A1 Cyclohexanecarboxylic acid compound |
| 02/03/2005 | CA2533397A1 Substituted pyridin-2-ylamine analogues |
| 02/03/2005 | CA2532980A1 2-aminopyrimidine and 2-aminopyridine-4-carbamates for use in the treatment of autoimmune diseases |
| 02/03/2005 | CA2532400A1 Tyrosine kinase inhibitors |
| 02/03/2005 | CA2532248A1 Novel compounds |
| 02/03/2005 | CA2532231A1 Aminopyrazole compounds and use as chk1 inhibitors |
| 02/03/2005 | CA2532154A1 Quinoline derivates and their use in therapy |
| 02/03/2005 | CA2532064A1 Hydroxypyridine cgrp receptor antagonists |
| 02/03/2005 | CA2531490A1 Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 02/03/2005 | CA2528586A1 Cyclohexanecarboxylic acid compound |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501826A2 Substituted indoles as alpha-1 agonists |
| 02/02/2005 | EP1501825A2 Substituted imidazolylmethyl pyridine and pyrazine derivatives: gaba a receptor ligands |
| 02/02/2005 | EP1501822A1 Phthalazinone derivatives |
| 02/02/2005 | EP1501809A1 Triazole derivatives as tachykinin receptor antagonists |